Conventional monoclonal antibodies have been exploited to conjugate with fluorescence imaging molecules to obtain tumor selectivity, and realize precise tumor imaging and resection, such as SGM101, a CEA monoclonal antibody conjugated with fluorochrome BM104 for fluorescence-guided surgery to detect CRC and metastasis [39]. This evidence concerns the gene CEACAM5 and neoplasm.